help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weiss, R. E.
Right arrow Articles by Refetoff, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weiss, R. E.
Right arrow Articles by Refetoff, S.

Journal of Clinical Endocrinology & Metabolism, Vol 81, 4196-4203, Copyright © 1996 by Endocrine Society


ARTICLES

Dominant inheritance of resistance to thyroid hormone not linked to defects in the thyroid hormone receptor alpha or beta genes may be due to a defective cofactor

RE Weiss, Y Hayashi, T Nagaya, KJ Petty, Y Murata, H Tunca, H Seo and S Refetoff
Department of Medicine, University of Chicago, Illinois 60637, USA. rweiss@medicine.bsd.uchicago.edu

Resistance to thyroid hormone (RTH) is an inherited syndrome of reduced tissue responsiveness to thyroid hormone. To date, all individuals expressing the RTH phenotype have been found to harbor mutations in the thyroid hormone receptor beta (TR beta) gene that impair T3-mediated function. We describe a unique family in which the dominantly inherited RTH is not associated with abnormalities in the TR beta or TR alpha genes, as determined by gene sequencing and linkage analysis. However, affected family members manifest a severe form of RTH, with reduced responses of thyrotrophs and peripheral tissues requiring 8- to 10-fold the normal replacement doses of L-T4 and L-T3. No other endocrine abnormalities were detected. The defect developed de novo in the proposita and was transmitted to her two children of unrelated fathers. As cultured fibroblasts from the proposita responded poorly to T3 despite a normal concentration of TR, other abnormalities in the mediation of T3 action were sought. Nucleotide sequences of the TSH beta promoter, containing thyroid hormone response elements, and TR- interacting protein 1 were normal. Nuclear extracts (NE) of cultured skin fibroblasts from affected individuals of this family were tested for their interaction with normal TR beta and thyroid hormone response elements by the electrophoretic mobility shift assay. NE from the proposita showed a strong additional band compared to NEs from normal individuals and patients with RTH caused by TR beta mutations or deletion. Far Western analysis of NE from the affected daughter hybridized with labeled TR beta demonstrated an additional band that was not seen in NEs from a normal control or patients with TR beta gene defects. It is concluded that the etiology of RTH is not confined to abnormalities in the TR beta gene. An abnormal cofactor with a specific function in the regulation of thyroid hormone action is probably involved in the expression of the RTH phenotype in this family.


This article has been cited by other articles:


Home page
Postgrad. Med. J.Home page
N K Agrawal, R Goyal, A Rastogi, D Naik, and S K Singh
Thyroid hormone resistance
Postgrad. Med. J., September 1, 2008; 84(995): 473 - 477.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Mamanasiri, S. Yesil, A. M. Dumitrescu, X.-H. Liao, T. Demir, R. E. Weiss, and S. Refetoff
Mosaicism of a Thyroid Hormone Receptor-{beta} Gene Mutation in Resistance to Thyroid Hormone
J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3471 - 3477.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
W. Wan, B. Farboud, and M. L. Privalsky
Pituitary Resistance to Thyroid Hormone Syndrome Is Associated with T3 Receptor Mutants that Selectively Impair {beta}2 Isoform Function
Mol. Endocrinol., June 1, 2005; 19(6): 1529 - 1542.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. C. Moeller, A. M. Dumitrescu, R. L. Walker, P. S. Meltzer, and S. Refetoff
Thyroid Hormone Responsive Genes in Cultured Human Fibroblasts
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 936 - 943.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. Kopp
Perspective: Genetic Defects in the Etiology of Congenital Hypothyroidism
Endocrinology, June 1, 2002; 143(6): 2019 - 2024.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. A. R. Neves, R. R. Cavalieri, L. A. Simeoni, D. G. Gardner, J. D. Baxter, B. F. Scharschmidt, N. Lomri, and R. C. J. Ribeiro
Thyroid Hormone Export Varies among Primary Cells and Appears to Differ from Hormone Uptake
Endocrinology, February 1, 2002; 143(2): 476 - 483.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. J. Kahaly, C. H. Matthews, S. Mohr-Kahaly, C. A. Richards, and V. K. K. Chatterjee
Cardiac Involvement in Thyroid Hormone Resistance
J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 204 - 212.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. A. Phillips, P. Rotman-Pikielny, J. Lazar, S. Ando, P. Hauser, M. C. Skarulis, F. Brucker-Davis, and P. M. Yen
Extreme Thyroid Hormone Resistance in a Patient with a Novel Truncated TR Mutant
J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5142 - 5147.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
P. M. Yen
Physiological and Molecular Basis of Thyroid Hormone Action
Physiol Rev, July 1, 2001; 81(3): 1097 - 1142.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Reutrakul, P. M. Sadow, S. Pannain, J. Pohlenz, G. A. Carvalho, P. E. Macchia, R. E. Weiss, and S. Refetoff
Search for Abnormalities of Nuclear Corepressors, Coactivators, and a Coregulator in Families with Resistance to Thyroid Hormone without Mutations in Thyroid Hormone Receptor {beta} or {alpha} Genes
J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3609 - 3617.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
M. Anafi, Y.-F. Yang, N. A. Barlev, M. V. Govindan, S. L. Berger, T. R. Butt, and P. G. Walfish
GCN5 and ADA Adaptor Proteins Regulate Triiodothyronine/GRIP1 and SRC-1 Coactivator-Dependent Gene Activation by the Human Thyroid Hormone Receptor
Mol. Endocrinol., May 1, 2000; 14(5): 718 - 732.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Pohlenz, R. E. Weiss, P. E. Macchia, S. Pannain, I. T. Lau, H. Ho, and S. Refetoff
Five New Families with Resistance to Thyroid Hormone not Caused by Mutations in the Thyroid Hormone Receptor {beta} Gene
J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 3919 - 3928.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
R. E. Weiss and S. Refetoff
Editorial: Treatment of Resistance to Thyroid Hormone--Primum Non Nocere
J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 401 - 404.
[Full Text]


Home page
EndocrinologyHome page
T. Tagami and J. L. Jameson
Nuclear Corepressors Enhance the Dominant Negative Activity of Mutant Receptors That Cause Resistance to Thyroid Hormone
Endocrinology, February 1, 1998; 139(2): 640 - 650.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-K. Lee, B. Lee, and J. W. Lee
Mutations in Retinoid X Receptor That Impair Heterodimerization with Specific Nuclear Hormone Receptor
J. Biol. Chem., October 20, 2000; 275(43): 33522 - 33526.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society